<DOC>
	<DOCNO>NCT00400309</DOCNO>
	<brief_summary>Primary objective : - To describe safety profile Tetanus , Diphtheria , Poliomyelitis Pertussis vaccine ( REPEVAX® ) administer pertussis booster 1 month Tetanus , Diphtheria , Poliomyelitis vaccine ( REVAXIS® ) compare safety profile REPEVAX® administer one month Placebo . Secondary objective : - To describe safety Td-IPV vaccine ( REVAXIS® ) Placebo administer healthy adult . - To describe safety TdaP-IPV vaccine ( REPEVAX® ) administer one month Td-IPV vaccine ( REVAXIS® ) one month Placebo .</brief_summary>
	<brief_title>Safety REPEVAX® Given One Month After REVAXIS®</brief_title>
	<detailed_description />
	<criteria>Healthy adult , vaccination history ( write evidence ) minimum 5 dos tetanus , diphtheria poliomyelitis contain vaccine recommend French vaccination calendar 18 year old , maximum 8 dos . Last dose tetanus and/or diphtheria and/or poliomyelitis contain vaccine administer either alone combination least 5 year prior administration first study vaccine . Prior know hypersensitivity reaction diphtheria and/or tetanus and/or poliomyelitis and/or pertussis contain vaccine Any current ( ≤ 3 day ) significant underlying disease acute febrile illness ( oral temperature ≥37.5°C ) Known immunological deficiency Known malignant disease Known neurological disorder Any longterm ( ≥ 14 day ) non steroid antiinflammatory therapy give daily within previous 30 day Known history severe thrombocytopenia coagulation disorder would contraindicate intramuscular injection Any previous ( ≤ 90 day ) administration bloodderived product immunoglobulin schedule administer Visit 3 Any recent administration ( ≤ 30 day ) vaccine schedule vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>